0x43b8…8aeb

All memos sent from and to 0x43b8…8aeb.

https://nature.com/articles/s41467-024-47745-z > We also observed an increased risk of appendicitis in the 1 42 days following the second dose of ChAdOX1 (IRR 4.64, 95%CI 1.77 12.17; excess events per million: 512, 95%CI 283 599) > We identified additional increased risks of anaphylaxis and appendicitis in 12-17-year-olds following a first dose of BNT162b2 (unadjusted IRR 3.71, 95%CI 1.23 11.14 and unadjusted IRR 1.37, 95%CI 1.05 1.80, respectively)
> The COVID-19 vaccines produce robust Th1 immune responses and there is a hypothesised link between an increased Th1 immune response and a sub-type of appendicitis that is likely to require surgery https://www.sciencedirect.com/science/article/pii/S2590136221000395
> We used a data set involving more than 2.4 million vaccinated persons from an integrated health care organization to evaluate the safety profile of the BNT162b2 mRNA Covid-19 vaccine. The main potential adverse events identified included an excess risk of lymphadenopathy (78.4 events per 100,000 persons), herpes zoster infection (15.8 events), appendicitis (5.0 events), and myocarditis (2.7 events) > To place these risks in context, we also examined data on more than 240,000 infected persons to estimate the effects of a documented SARS-CoV-2 infection on the incidence of the same adverse events. SARS-CoV-2 infection was not estimated to have a meaningful effect on the incidence of lymphadenopathy, herpes zoster infection, or appendicitis https://www.nejm.org/doi/10.1056/NEJMoa2110475
> Appendicitis was reported as a serious adverse event for 12 participants, and numerically higher in the vaccine group, 8 vaccine participants and 4 placebo participants. https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/pfizer-biontech-covid-19-vaccine#additional
> The Pfizer and Moderna randomized trials ended after less than 6 months when those who had received the placebo were offered vaccination. This meant there was no randomized information on long term efficacy and adverse reactions. An argument can be made for ending the trial for older high-risk participants, but why was this time-frame selected for younger participants with low mortality risk? https://www.norfolkgroup.org/chapters/chapter-eight-covid-19-vaccines
> The core problem in post-vaccine syndrome is long-lasting immune dysregulation. The most important treatment goal is to help the body restore a healthy immune system https://covid19criticalcare.com/protocol/i-recover-post-vaccine-treatment
> emerging evidence suggests that the reported increase in IgG4 levels detected after repeated vaccination with the mRNA vaccines may not be a protective mechanism; rather, it constitutes an immune tolerance mechanism to the spike protein that could promote unopposed SARS-CoV2 infection and replication by suppressing natural antiviral responses. Increased IgG4 synthesis due to repeated mRNA vaccination with high antigen concentrations may also cause autoimmune diseases, and promote cancer growth and autoimmune myocarditis in susceptible individuals. https://www.mdpi.com/2076-393X/11/5/991
> A recent paper published in Science confirms what many of us have been saying for well over a year now: repeated injections with modified mRNA encapsulated by LNPs messes up your immune system. https://jessicar.substack.com/p/igg4-related-disease-igg4rd-means https://www.science.org/doi/10.1126/sciimmunol.ade2798
> Appendicitis was reported as a serious adverse event for 12 participants, and numerically higher in the vaccine group, 8 vaccine participants and 4 placebo participants ... > The Pfizer and Moderna randomized trials ended after less than 6 months when those who had received the placebo were offered vaccination. This meant there was no randomized information on long term efficacy and adverse reactions. https://norfolkgroup.org/chapters/chapter-eight-covid-19-vaccines